Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2020-11-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2020.617539/full |
| _version_ | 1818404665213059072 |
|---|---|
| author | Xiaoyi Hu Xiaoyi Hu Xiaoyi Hu Xiaoyi Hu Mingyang Bao Jiacheng Huang Jiacheng Huang Jiacheng Huang Jiacheng Huang Lin Zhou Lin Zhou Lin Zhou Shusen Zheng Shusen Zheng Shusen Zheng Shusen Zheng |
| author_facet | Xiaoyi Hu Xiaoyi Hu Xiaoyi Hu Xiaoyi Hu Mingyang Bao Jiacheng Huang Jiacheng Huang Jiacheng Huang Jiacheng Huang Lin Zhou Lin Zhou Lin Zhou Shusen Zheng Shusen Zheng Shusen Zheng Shusen Zheng |
| author_sort | Xiaoyi Hu |
| collection | DOAJ |
| first_indexed | 2024-12-14T08:43:46Z |
| format | Article |
| id | doaj.art-680ed91533584d3794b90f8e7d084a65 |
| institution | Directory Open Access Journal |
| issn | 2234-943X |
| language | English |
| last_indexed | 2024-12-14T08:43:46Z |
| publishDate | 2020-11-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj.art-680ed91533584d3794b90f8e7d084a652022-12-21T23:09:13ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2020-11-011010.3389/fonc.2020.617539617539Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular CarcinomaXiaoyi Hu0Xiaoyi Hu1Xiaoyi Hu2Xiaoyi Hu3Mingyang Bao4Jiacheng Huang5Jiacheng Huang6Jiacheng Huang7Jiacheng Huang8Lin Zhou9Lin Zhou10Lin Zhou11Shusen Zheng12Shusen Zheng13Shusen Zheng14Shusen Zheng15Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaNational Health and Family Planning Commission of China Key Laboratory of Combined Multi-Organ Transplantation, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaKey Laboratory of the Diagnosis and Treatment of Organ Transplantation, Research Unit of Collaborative Diagnosis and Treatment for Hepatobiliary and Pancreatic Cancer, Chinese Academy of Medical Sciences, Hangzhou, ChinaKey Laboratory of Organ Transplantation, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaState Key Laboratory of Genetic Engineering, School of Life Sciences, Institute of Biostatistics, Fudan University, Shanghai, ChinaDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaNational Health and Family Planning Commission of China Key Laboratory of Combined Multi-Organ Transplantation, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaKey Laboratory of the Diagnosis and Treatment of Organ Transplantation, Research Unit of Collaborative Diagnosis and Treatment for Hepatobiliary and Pancreatic Cancer, Chinese Academy of Medical Sciences, Hangzhou, ChinaKey Laboratory of Organ Transplantation, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaNational Health and Family Planning Commission of China Key Laboratory of Combined Multi-Organ Transplantation, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaKey Laboratory of the Diagnosis and Treatment of Organ Transplantation, Research Unit of Collaborative Diagnosis and Treatment for Hepatobiliary and Pancreatic Cancer, Chinese Academy of Medical Sciences, Hangzhou, ChinaKey Laboratory of Organ Transplantation, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaDivision of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaNational Health and Family Planning Commission of China Key Laboratory of Combined Multi-Organ Transplantation, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, ChinaKey Laboratory of the Diagnosis and Treatment of Organ Transplantation, Research Unit of Collaborative Diagnosis and Treatment for Hepatobiliary and Pancreatic Cancer, Chinese Academy of Medical Sciences, Hangzhou, ChinaKey Laboratory of Organ Transplantation, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Chinahttps://www.frontiersin.org/articles/10.3389/fonc.2020.617539/fullprognosisbiomarkerGEOhepatocellular carcinoma (HCC)diagnosis |
| spellingShingle | Xiaoyi Hu Xiaoyi Hu Xiaoyi Hu Xiaoyi Hu Mingyang Bao Jiacheng Huang Jiacheng Huang Jiacheng Huang Jiacheng Huang Lin Zhou Lin Zhou Lin Zhou Shusen Zheng Shusen Zheng Shusen Zheng Shusen Zheng Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma Frontiers in Oncology prognosis biomarker GEO hepatocellular carcinoma (HCC) diagnosis |
| title | Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma |
| title_full | Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma |
| title_fullStr | Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma |
| title_full_unstemmed | Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma |
| title_short | Corrigendum: Identification and Validation of Novel Biomarkers for Diagnosis and Prognosis of Hepatocellular Carcinoma |
| title_sort | corrigendum identification and validation of novel biomarkers for diagnosis and prognosis of hepatocellular carcinoma |
| topic | prognosis biomarker GEO hepatocellular carcinoma (HCC) diagnosis |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2020.617539/full |
| work_keys_str_mv | AT xiaoyihu corrigendumidentificationandvalidationofnovelbiomarkersfordiagnosisandprognosisofhepatocellularcarcinoma AT xiaoyihu corrigendumidentificationandvalidationofnovelbiomarkersfordiagnosisandprognosisofhepatocellularcarcinoma AT xiaoyihu corrigendumidentificationandvalidationofnovelbiomarkersfordiagnosisandprognosisofhepatocellularcarcinoma AT xiaoyihu corrigendumidentificationandvalidationofnovelbiomarkersfordiagnosisandprognosisofhepatocellularcarcinoma AT mingyangbao corrigendumidentificationandvalidationofnovelbiomarkersfordiagnosisandprognosisofhepatocellularcarcinoma AT jiachenghuang corrigendumidentificationandvalidationofnovelbiomarkersfordiagnosisandprognosisofhepatocellularcarcinoma AT jiachenghuang corrigendumidentificationandvalidationofnovelbiomarkersfordiagnosisandprognosisofhepatocellularcarcinoma AT jiachenghuang corrigendumidentificationandvalidationofnovelbiomarkersfordiagnosisandprognosisofhepatocellularcarcinoma AT jiachenghuang corrigendumidentificationandvalidationofnovelbiomarkersfordiagnosisandprognosisofhepatocellularcarcinoma AT linzhou corrigendumidentificationandvalidationofnovelbiomarkersfordiagnosisandprognosisofhepatocellularcarcinoma AT linzhou corrigendumidentificationandvalidationofnovelbiomarkersfordiagnosisandprognosisofhepatocellularcarcinoma AT linzhou corrigendumidentificationandvalidationofnovelbiomarkersfordiagnosisandprognosisofhepatocellularcarcinoma AT shusenzheng corrigendumidentificationandvalidationofnovelbiomarkersfordiagnosisandprognosisofhepatocellularcarcinoma AT shusenzheng corrigendumidentificationandvalidationofnovelbiomarkersfordiagnosisandprognosisofhepatocellularcarcinoma AT shusenzheng corrigendumidentificationandvalidationofnovelbiomarkersfordiagnosisandprognosisofhepatocellularcarcinoma AT shusenzheng corrigendumidentificationandvalidationofnovelbiomarkersfordiagnosisandprognosisofhepatocellularcarcinoma |